191 related articles for article (PubMed ID: 25558000)
1. Tissue inhibitor of metalloproteinase-3 (TIMP3) promotes endothelial apoptosis via a caspase-independent mechanism.
Qi JH; Anand-Apte B
Apoptosis; 2015 Apr; 20(4):523-34. PubMed ID: 25558000
[TBL] [Abstract][Full Text] [Related]
2. Deglycosylation Increases the Aggregation and Angiogenic Properties of Mutant Tissue Inhibitor of Metalloproteinase 3 Protein: Implications for Sorsby Fundus Dystrophy.
Qi JH; Anand-Apte B
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430707
[TBL] [Abstract][Full Text] [Related]
3. Cell surface-bound TIMP3 induces apoptosis in mesenchymal Cal78 cells through ligand-independent activation of death receptor signaling and blockade of survival pathways.
Koers-Wunrau C; Wehmeyer C; Hillmann A; Pap T; Dankbar B
PLoS One; 2013; 8(7):e70709. PubMed ID: 23894681
[TBL] [Abstract][Full Text] [Related]
4. Molecular dissection of TIMP3 mutation S156C associated with Sorsby fundus dystrophy.
Fogarasi M; Janssen A; Weber BH; Stöhr H
Matrix Biol; 2008 Jun; 27(5):381-92. PubMed ID: 18295466
[TBL] [Abstract][Full Text] [Related]
5. TIMP3/TGF‑β1 axis regulates mechanical loading‑induced chondrocyte degeneration and angiogenesis.
Zhao DL; Li HT; Liu SH
Mol Med Rep; 2020 Oct; 22(4):2637-2644. PubMed ID: 32945489
[TBL] [Abstract][Full Text] [Related]
6. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.
Qi JH; Claesson-Welsh L
Exp Cell Res; 2001 Feb; 263(1):173-82. PubMed ID: 11161716
[TBL] [Abstract][Full Text] [Related]
7. Abnormal vessel formation in the choroid of mice lacking tissue inhibitor of metalloprotease-3.
Janssen A; Hoellenriegel J; Fogarasi M; Schrewe H; Seeliger M; Tamm E; Ohlmann A; May CA; Weber BH; Stöhr H
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2812-22. PubMed ID: 18408187
[TBL] [Abstract][Full Text] [Related]
8. The Angiogenic Effect of microRNA-21 Targeting TIMP3 through the Regulation of MMP2 and MMP9.
Hu J; Ni S; Cao Y; Zhang T; Wu T; Yin X; Lang Y; Lu H
PLoS One; 2016; 11(2):e0149537. PubMed ID: 26872030
[TBL] [Abstract][Full Text] [Related]
9. Tissue inhibitor of metalloproteinases 3 regulates extracellular matrix--cell signaling during bronchiole branching morphogenesis.
Gill SE; Pape MC; Leco KJ
Dev Biol; 2006 Oct; 298(2):540-54. PubMed ID: 16890932
[TBL] [Abstract][Full Text] [Related]
10. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
11. Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation.
Kwak HJ; Park MJ; Park CM; Moon SI; Yoo DH; Lee HC; Lee SH; Kim MS; Lee HW; Shin WS; Park IC; Rhee CH; Hong SI
Int J Cancer; 2006 Jun; 118(11):2711-20. PubMed ID: 16388516
[TBL] [Abstract][Full Text] [Related]
12. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.
Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J
Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043
[TBL] [Abstract][Full Text] [Related]
13. Tissue inhibitor of metalloproteinases-3 transfer suppresses malignant behaviors of colorectal cancer cells.
Lin H; Zhang Y; Wang H; Xu D; Meng X; Shao Y; Lin C; Ye Y; Qian H; Wang S
Cancer Gene Ther; 2012 Dec; 19(12):845-51. PubMed ID: 23037807
[TBL] [Abstract][Full Text] [Related]
14. Tissue inhibitor of metalloproteinases 3-dependent microvascular endothelial cell barrier function is disrupted under septic conditions.
Arpino V; Mehta S; Wang L; Bird R; Rohan M; Pape C; Gill SE
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1455-67. PubMed ID: 26993226
[TBL] [Abstract][Full Text] [Related]
15. Differential TIMP3 expression affects tumor progression and angiogenesis in melanomas through regulation of directionally persistent endothelial cell migration.
Das AM; Seynhaeve AL; Rens JA; Vermeulen CE; Koning GA; Eggermont AM; Ten Hagen TL
Angiogenesis; 2014 Jan; 17(1):163-77. PubMed ID: 24221409
[TBL] [Abstract][Full Text] [Related]
16. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2.
Qi JH; Ebrahem Q; Moore N; Murphy G; Claesson-Welsh L; Bond M; Baker A; Anand-Apte B
Nat Med; 2003 Apr; 9(4):407-15. PubMed ID: 12652295
[TBL] [Abstract][Full Text] [Related]
17. Caspase 3-mediated focal adhesion kinase processing in human ovarian cancer cells: possible regulation by X-linked inhibitor of apoptosis protein.
Sasaki H; Kotsuji F; Tsang BK
Gynecol Oncol; 2002 May; 85(2):339-50. PubMed ID: 11972398
[TBL] [Abstract][Full Text] [Related]
18. Timp3 loss accelerates tumour invasion and increases prostate inflammation in a mouse model of prostate cancer.
Adissu HA; McKerlie C; Di Grappa M; Waterhouse P; Xu Q; Fang H; Khokha R; Wood GA
Prostate; 2015 Dec; 75(16):1831-43. PubMed ID: 26332574
[TBL] [Abstract][Full Text] [Related]
19. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells.
Miura S; Matsuo Y; Saku K
Hypertension; 2003 May; 41(5):1118-23. PubMed ID: 12654712
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylinositol 3-kinase/Akt regulates angiotensin II-induced inhibition of apoptosis in microvascular endothelial cells by governing survivin expression and suppression of caspase-3 activity.
Ohashi H; Takagi H; Oh H; Suzuma K; Suzuma I; Miyamoto N; Uemura A; Watanabe D; Murakami T; Sugaya T; Fukamizu A; Honda Y
Circ Res; 2004 Apr; 94(6):785-93. PubMed ID: 14963002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
